Research
Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target
Benitec Biopharma (BNTC) has an average rating of buy and mean price target of $25.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$BNTC
